SUPRIYA NSE filing

Supriya Lifescience Announces 18th AGM on Sept 24, 2026; Annual Report Available Online

The RealCase readLow impact Neutral

Supriya Lifescience Limited will hold its 18th Annual General Meeting on September 24, 2026, via VC/OAVM. The Annual Report for FY 2025-26 is available online for shareholders.

Why it matters

This is a standard procedural announcement related to corporate governance and regulatory compliance, unlikely to have a significant impact on the company's stock price or operations.

The market read

The announcement is a routine corporate disclosure regarding the AGM and availability of the annual report, with no significant financial or operational updates.

Supriya Lifescience Limited has announced that its 18th Annual General Meeting (AGM) will be held on Thursday, September 24, 2026, at 3:00 PM IST. The meeting will be conducted through Video Conferencing / Other Audio Visual Means (VC/OAVM) in compliance with relevant regulations.

The company is also providing access to its Annual Report for the Financial Year 2025-26. A communication containing a web link to the Annual Report has been sent to shareholders whose email IDs are not registered with the Company, its Registrar and Transfer Agent (RTA), or their Depository Participants. The Annual Report and the Notice convening the 18th AGM can be accessed via the web link: https://www.supriyalifescience.com/ir-annual-report-return.php. Additionally, the Annual Report and AGM notice are available on the websites of BSE Limited (www.bseindia.com), National Stock Exchange of India Limited (www.nseindia.com), and NSDL (www.evoting.nsdl.com).

This communication regarding the Annual Report is being sent to members who had not registered their email addresses with the Company, any Depository, or the RTA as of the cut-off date, August 21, 2026. Shareholders are encouraged to register their email addresses with their respective Depository Participants for future electronic communications.

Primary source

A plain-language summary of a public exchange filing by Supriya Lifescience Limited. Read the original for the full detail.

View original filing
This is RealCase

Every move, explained.

Expert model portfolios with exact weights, an Active or Hold state on every holding, and a written reason behind every change. In your pocket.

Coming soon toApp StoreComing soon toGoogle Play
100% digital · your money stays in your own broker · your data is secure
RealCase
Your RealCases
Core Compounders
Stocks
13.4%
Flexi Core
Mutual Funds
13.1%
Latest change
ActiveHDFC Bank10% → 14%

“Deposits growing faster than loans again. We add on strength, funded from cash.”

₹0Commission · fee-only